Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandria Phan

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2008
Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control studyManal M Hassan, Alexandria Phan, Donghui Li, et al.
International Journal of Cancer|May 21, 2008
Risk factors associated with neuroendocrine tumors: A U.S.-based case-control studyManal M Hassan, Alexandria Phan, Donghui Li, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 27, 2022
A qualitative study to understand the experience of somatostatin analog treatments from the perspective of patients with neuroendocrine tumorsCaroline Seo, Erica Horodniceanu, Rachel Shah, et al.
The Oncologist|April 25, 2019
Patterns of Care Among Real-World Patients with Metastatic Neuroendocrine TumorsAndrew J Klink, Bruce Feinberg, Hsing-Ting Yu, et al.
Annals of Surgical Oncology|September 27, 2007
Population-based study of islet cell carcinomaJames C Yao, Milton P Eisner, Colleen Leary, et al.
Cancer|January 29, 2010
Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancerMichael J Overman, Syed M Kazmi, Jagriti Jhamb, et al.
American Journal of Clinical Oncology|February 25, 2016
A Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients With Untreated Locally Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal JunctionMariela A Blum Murphy, Wei Qiao, Nishith Mewada, et al.
Cancer|October 19, 2011
Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experienceMontserrat Ayala-Ramirez, Lei Feng, Mouhammed A Habra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Decreased expression of gene cluster at chromosome 1q21 defines molecular subgroups of chemoradiotherapy response in esophageal cancersMadan G Luthra, Jaffer A Ajani, Julie Izzo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experienceShulian Wang, Zhongxing Liao, Yuan Chen, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 10, 2008
Family history of cancer and associated risk of developing neuroendocrine tumors: a case-control studyManal M Hassan, Alexandria Phan, Donghui Li, et al.
International Journal of Cancer|May 21, 2008
Risk factors associated with neuroendocrine tumors: A U.S.-based case-control studyManal M Hassan, Alexandria Phan, Donghui Li, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 27, 2022
A qualitative study to understand the experience of somatostatin analog treatments from the perspective of patients with neuroendocrine tumorsCaroline Seo, Erica Horodniceanu, Rachel Shah, et al.
The Oncologist|April 25, 2019
Patterns of Care Among Real-World Patients with Metastatic Neuroendocrine TumorsAndrew J Klink, Bruce Feinberg, Hsing-Ting Yu, et al.
Annals of Surgical Oncology|September 27, 2007
Population-based study of islet cell carcinomaJames C Yao, Milton P Eisner, Colleen Leary, et al.
Cancer|January 29, 2010
Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancerMichael J Overman, Syed M Kazmi, Jagriti Jhamb, et al.
American Journal of Clinical Oncology|February 25, 2016
A Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients With Untreated Locally Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal JunctionMariela A Blum Murphy, Wei Qiao, Nishith Mewada, et al.
Cancer|October 19, 2011
Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experienceMontserrat Ayala-Ramirez, Lei Feng, Mouhammed A Habra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Decreased expression of gene cluster at chromosome 1q21 defines molecular subgroups of chemoradiotherapy response in esophageal cancersMadan G Luthra, Jaffer A Ajani, Julie Izzo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experienceShulian Wang, Zhongxing Liao, Yuan Chen, et al.
Pageof 4